![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Viral Responses in African Americans, Latinos, and Caucasians in the US Phase 2 Study (PROVE1) of Telaprevir with Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve, Genotype 1-Infected Patients with Hepatitis C
|
|
|
AASLD 2008 SF
Reported by Jules Levin
Andrew J Muir,1 Eric J Lawitz,2 John G McHutchison,1 Stuart C Gordon,3 Ira M Jacobson,4 Bambang S Adiwijaya,5 Leif Bengtsson,5 Lindsay McNair,5 Maribel Rodriguez-Torres6
1Duke Clinical Research Institute, Durham, NC, USA; 2Alamo Medical Research, San Antonio, TX, USA; 3Henry Ford Hospital, Detroit, MI, USA; 4Weill Medical College of Cornell University, New York, NY, USA; 5Vertex Pharmaceuticals Incorporated, Boston, MA, USA; 6Fundacion de Investigacion de Diego, Ponce School of Medicine, San Juan, Puerto Rico
![summ-1.gif](../../2009/images/092909/092909-2/summ-1.gif)
![cons-2.gif](../../2009/images/092909/092909-2/cons-2.gif)
![back-3.gif](../../2009/images/092909/092909-2/back-3.gif)
![Methos-4.gif](../../2009/images/092909/092909-2/Methos-4.gif)
![race-5.gif](../../2009/images/092909/092909-2/race-5.gif)
![result-6.gif](../../2009/images/092909/092909-2/result-6.gif)
![Tpr-7.gif](../../2009/images/092909/092909-2/Tpr-7.gif)
![RVR-8.gif](../../2009/images/092909/092909-2/RVR-8.gif)
![recdent-9.gif](../../2009/images/092909/092909-2/recdent-9.gif)
![africn-10.gif](../../2009/images/092909/092909-2/africn-10.gif)
![Dyn-11.gif](../../2009/images/092909/092909-2/Dyn-11.gif)
![events-12.gif](../../2009/images/092909/092909-2/events-12.gif)
![REfer-13.gif](../../2009/images/092909/092909-2/REfer-13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|